The Present and Future of Colorectal Cancer Screening

• Published in: Gastroenterology & hepatology Vol. 18; no. 11; pp. 646 - 653
• Main Authors: Chung, Samantha S, Ali, Sara I, Cash, Brooks D
• Format: Journal Article
• Language: English
• Published: United States Millennium Medical Publishing 01.11.2022
• Subjects: Column; Colorectal cancer screening; guidelines; colonoscopy; stool DNA; colon capsule endoscopy; computed tomography colonography
• ISSN: 1554-7914

There have been multiple recent updates for recommendations pertaining to colorectal cancer (CRC) screening. Among the most notable is the recommendation from several guideline-issuing bodies to initiate CRC screening examinations at 45 years of age for individuals at average risk for CRC. Current CRC screening methods include stool-based tests and colon visualization examinations. Currently recommended stool-based tests include fecal immunochemical testing, high-sensitivity guaiac-based fecal occult blood testing, and multitarget stool DNA testing. Visualization examinations include colonoscopy, computed tomography colonography, colon capsule endoscopy, and flexible sigmoidoscopy. Although these screening tests have shown encouraging results for CRC detection, there are important differences between these testing modalities for precursor lesion detection and management. In addition, emerging CRC screening methods are being developed and evaluated. However, additional large, multicenter clinical trials in diverse populations are needed to validate the diagnostic accuracy and generalizability of these new tests. This article reviews the recently updated CRC screening recommendations and current and emerging testing options.